Steroidogenic responses of pig corpora lutea to insulin-like growth factor I (IGF-I) throughout the oestrous cycle

被引:17
|
作者
Miller, EA [1 ]
Ge, Z [1 ]
Hedgpeth, V [1 ]
Gadsby, JE [1 ]
机构
[1] N Carolina State Univ, Coll Vet Med, Dept Mol Biomed Sci, Raleigh, NC 27606 USA
关键词
D O I
10.1530/rep.0.1250241
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
This study was designed to investigate the roles of insulin-like growth factor I (IGF-I), IGF-type I receptor (IGF-IR) and IGF-binding proteins (IGFBPs) in regulating progesterone secretion by pig corpora lutea during the oestrous cycle, and the signal transduction pathways involved in mediating the steroidogenic actions of IGF-I. Corpora lutea were collected on days 4, 7, 10, 13 and 15 or 16 of the oestrous cycle, enzyme dissociated and the luteal cells were cultured for 24 h in Medium 199 with IGF-I (0-100 ng ml(-1)), long R-3-IGF-I (0-100 ng ml(-1)), anti-IGF-I (Sm 1.2B; 0-10 mug ml(-1)), anti-IGF-IR (alphaIR3; 0-2 mug ml(-1)), or lGF-l signal transduction pathway inhibitors (phosphatidylinositol (PI)-3-kinase: 100 nmol Wortmannin l(-1) and 10 mumol LY 294002 l(-1); MAP kinase: 50 mumol PD 98059 l(-1)) to investigate their effects on IGF-I (100 ng ml(-1)) stimulated progesterone secretion. Pig luteal cells displayed dose-dependent responses to IGF-I and long R-3-IGF-I on days 4 and 7 of the oestrous cycle, but not on days 10-16. There was no difference in the ED50 or V-max (maximal response) values between lGF-l and long R-3-IGF-I. Neither anti-IGF-I nor anti-IGF-IR had significant effects on progesterone secretion, at any dose or day. Wortmannin and LY 294002 blocked IGF-I stimulated progesterone secretion, but PD 98059 was without effect. Finally, IGF-I (6 mug) infused into the ovary on day 7 in vivo significantly increased progesterone secretion within 45 min of infusion. The conclusions of this study are: (1) IGF-I has steroidogenic actions only on 'young' (days 4-7) pig corpora lutea; (2) endogenous IGF-I and IGFBP are insufficient to modulate progesterone secretion in vitro; and (3) the steroidogenic actions of IGF-I are mediated via PI-3-kinase.
引用
收藏
页码:241 / 249
页数:9
相关论文
共 50 条
  • [21] EXPRESSION OF INSULIN-LIKE GROWTH-FACTOR-I (IGF-I) IN MARMOSET OVARY
    RODWAY, MR
    BIOLOGY OF REPRODUCTION, 1994, 50 : 122 - 122
  • [22] The role of serum insulin-like growth factor I (IGF-I) in neonatal outcome
    Hayati, AR
    Cheah, FC
    Yong, JF
    Tan, AE
    Norizah, WM
    JOURNAL OF CLINICAL PATHOLOGY, 2004, 57 (12) : 1299 - 1301
  • [23] Human conditions of insulin-like growth factor-I (IGF-I) deficiency
    Puche, Juan E.
    Castilla-Cortazar, Inma
    JOURNAL OF TRANSLATIONAL MEDICINE, 2012, 10
  • [24] Issues in liquid formulation development for insulin-like Growth Factor I (IGF-I).
    Shirley, BA
    Bajwa, KK
    Lone, TA
    Arellano, SL
    Hora, MS
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 216 : U239 - U239
  • [25] EXPRESSION OF INSULIN-LIKE GROWTH-FACTOR-I (IGF-I) IN NEVI AND MELANOMAS
    FLEMING, MG
    HOWE, SF
    GRAF, LH
    AMERICAN JOURNAL OF DERMATOPATHOLOGY, 1994, 16 (04) : 383 - 391
  • [26] TAMOXIFEN REDUCES SERUM INSULIN-LIKE GROWTH FACTOR-I (IGF-I)
    POLLAK, MN
    HUYNH, H
    LEFEBVRE, SP
    BREAST CANCER RESEARCH AND TREATMENT, 1992, 22 (01) : 91 - 100
  • [27] Localization of Insulin-Like Growth Factor-I (IGF-I) and IGF-I Receptor (IGF-IR) in Equine Testes
    Yoon, M. J.
    Berger, T.
    Roser, J. F.
    REPRODUCTION IN DOMESTIC ANIMALS, 2011, 46 (02) : 221 - 228
  • [28] DISTRIBUTION OF CIRCULATING INSULIN-LIKE GROWTH FACTOR-I (IGF-I) INTO TISSUES
    HODGKINSON, SC
    SPENCER, GSG
    BASS, JJ
    DAVIS, SR
    GLUCKMAN, PD
    ENDOCRINOLOGY, 1991, 129 (04) : 2085 - 2093
  • [29] Insulin-like growth factor-I (IGF-I) receptors in breast cancer
    Pezzino, V
    Papa, V
    Milazzo, G
    Gliozzo, B
    Russo, P
    Scalia, PL
    BASIS FOR CANCER MANAGEMENT, 1996, 784 : 189 - 201
  • [30] Insulin-like growth factor-I (IGF-I) prevents steroid myopathy
    Kanda, F
    Takatani, K
    Matsushita, T
    Okuda, S
    Chihara, K
    NEUROLOGY, 1997, 48 (03) : 5074 - 5074